IDYA

NASDAQ · Biotechnology

Ideaya Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$38.41

-0.20 (-0.52%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 91%

Hold 2 9%

Sell 0 0%

Price Target

Analyst Price Target +206.4% upside

Low Target $81.99

Average Target $117.67

High Target $158.58

Current Price $38.41

Current
$38.41

Target
$117.67

$81.99 $117.67 avg $158.58

Scenario Analysis

Bear Case

$81.99

113.5%

Low target

Base Case

$117.67

+206.4%

Avg target

Bull Case

$158.58

+312.9%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$42.68

-10.0% from high

52-Week Low

$24.28

+58.2% from low

50-Day SMA

$34.24

+12.2% vs SMA

200-Day SMA

$27.52

+39.6% vs SMA

RSI (14)

49.6

Neutral

Target vs 52W High

$117.67

+175.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.7%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-3.0%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%